Cargando…
Myelin oligodendrocyte glycoprotein associated disorder following SARS-CoV-2 vaccination
Autores principales: | Bellakhdar, S., Maskaoui, J., Haddouali, K., El Moutawakil, B., Rafai, M.A., El Otmani, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938203/ https://www.ncbi.nlm.nih.gov/pubmed/35459457 http://dx.doi.org/10.1016/j.neurol.2022.01.008 |
Ejemplares similares
-
Alerte thrombolyse et la pandémie de la COVID-19 : quel impact ?
por: Noura, Iggar, et al.
Publicado: (2022) -
RBD and hyposmia in Moroccan patients with a synucleinopathy: prevalence and the timing of occurrence in a large cohort
por: El Otmani, Hicham, et al.
Publicado: (2023) -
Neuro-Covid-19 et population gériatrique : quelles particularités ?
por: Khattab, H., et al.
Publicado: (2022) -
Atypical Myelin Oligodendrocyte Glycoprotein Immunoglobulin G-Associated Disorder With Recurrent Meningoencephalitis
por: Kim, Jin-Ah, et al.
Publicado: (2021) -
No impact of confinement during COVID-19 pandemic on anxiety and depression in Parkinsonian patients
por: El Otmani, H., et al.
Publicado: (2021)